Risk Factor Analysis of Long-Term Support With Left Ventricular Assist System

    • SAITO Shunsuke
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
    • MATSUMIYA Goro
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
    • SAKAGUCHI Taichi
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
    • MIYAGAWA Shigeru
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine

    • YOSHIKAWA Yasushi
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
    • YAMAUCHI Takashi
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
    • KURATANI Toru
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine
    • SAWA Yoshiki
    • Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine

Abstract

Background: This study was designed to elucidate the key factors for successful long-term support with a left ventricular assist system (LVAS) in the situation where heart transplantation is rarely available. Methods and Results: From 1992 to 2008, 106 patients underwent 121 LVAS implantations at Osaka University Hospital (Toyobo: 77; Novacor: 18; HeartMate: 14; Jarvik2000: 8; EvaHeart: 2; DuraHeart: 2). Risk factors for infection were early on the former implanted period (odds ratio (OR) 3.30), Toyobo (OR 2.25), mechanical right heart support (OR 2.30) and cardiopulmonary bypass time (OR 1.01). Left atrium as the inflow site was the risk factor for cerebrovascular events (OR 2.84). Older age (OR 1.04) and mechanical right heart support (OR 4.70) were risk factors for mortality. Risk factors for requiring mechanical right heart support were preoperative extracorporeal membranous oxygenation support (OR 5.641), serum total bilirubin (OR 1.11) and serum creatinine (OR 2.46). On the basis of the risk analysis for mortality, patients were divided into 2 subgroups (low and high risk) and the respective cumulative survival at 1 year after LVAS implantation was 75.2% and 25.0%. Conclusions: Appropriate selection of device, patient and the timing of implantation and less invasive operation are important for successful long-term LVAS support. (Circ J 2010; 74: 715-722)

Journal

Circulation Journal  

Circulation Journal 74(4), 715-722, 2010-03-25 

Japanese Circulation Society.

References:  26

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Cited by:  7

You must have a user ID to see the cited references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Codes

  • NII Article ID (NAID) :
    10026472455
  • NII NACSIS-CAT ID (NCID) :
    AA11591968
  • Text Lang :
    ENG
  • Article Type :
    Journal Article
  • ISSN :
    13469843
  • Databases :
    CJP  CJPref  J-STAGE 

Export